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put together. The robustness was assessed by applying 
Hounsfield unit (HU) perturbations of 3.5% and isocenter 
shifts of 5mm. Single beam optimisation (SBO) using a 
horizontal beam line was used when possible. PTV constraints 
were D2% < 107%, D98% > 90% and V95% > 95% (ICRU). Limits 
to organs-at-risk (OAR) were the dose-surface area for the 
skin A60Gy (RBE) < 20cm2 [2], maximum dose to the bones 
DRBE, 2% < 60 Gy (RBE), maximum dose to the nerves and 
vessels DRBE, 2% < 70 Gy (RBE). 
[1] Haas et al 2012 IJROBP 84: 572-580 
[2] Sugahara et al 2012 RadiotherOncol 105: 226-231 
 
Results: Patients with field lengths < 18cm (PTV volumes: 
164-659 cm3) could be treated with SBO using 2 horizontal 
beams and table rotation. In the nominal plan, PTVV95% 
ranged from 96.3-98.9%. SkinA60Gy (RBE) was 10±7.5cm2. 
Treatment plans were robust against HU perturbations and 
5mm shifts in sup-inf and right-left direction with V95 never 
dropping below 93%. D2% and D98% of the PTV and OAR doses 
never exceeded the limits. Shifts of 5mm in ant-post 
direction caused severe underdosage in the PTV down to 
V95% of 68%. Robust optimisation in ant-post direction could 
increase these values up to 91%.  
For larger PTVs (420 cm3-2240cm3) field lengths ranged from 
25-34 cm. The length of the field overlapping region 
essentially influenced the robustness of the treatment plans. 
Isocenter shifts of 5mm to each other or apart resulted in a 
PTVD2% change of 7% for an overlap >6cm increasing up to 
15% for ≤ 6cm (Figure 1). 
 
 
Conclusion: Robust treatment plans could be achieved for 
ESTS patients employing a horizontal beam line only. Before 
clinical implementation, dosimetric monitoring of skin doses 
should be performed to verify the calculated values. If field 
matching is needed a maximal overlap of the matching fields 
should be guaranteed to avoid hot or cold spots in the 
overlapping area. 
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Purpose or Objective: During the last couple of years, 
volumetric modulated arc therapy (VMAT) is a treatment 
modality of increasing interest in radiation oncology. Thereby 
VMAT utilizes dynamic gantry rotation, dynamic MLC and 
varying dose rate. However, in addition the collimator angle 
could be changed dynamically, thus, increasing the degrees 
of freedom for the optimization, which might lead to 
improved dose distributions. This work investigates the 
feasibility of VMAT optimization including a dynamic 
collimator rotation. 
 
Material and Methods: In this work a 20 x 20 x 20 cm^3 
homogeneous water phantom with a cigar shaped target 
volume and a close-by spherical shaped critical structure was 
used. By means of the Eclipse Research Scripting a 
predefined collimator rotation was included to a partial arc 
in a not yet optimized treatment plan. For this purpose a 
different collimator angle was assigned for each dicom 
control point. Thereby the collimator rotation takes into 
account the physical limitations for the dose delivery. This 
treatment plan was then imported into the treatment 
planning system Eclipse using the Eclipse Research Scripting 
interface. Then the VMAT optimization was performed 
applying the PRO3 optimization algorithm in a research 
version of Eclipse. For the dose calculation of the optimized 
treatment plan the Swiss Monte Carlo Plan (SMCP) was used 
[1]. Similarly, a dose distribution was determined using a 
static collimator angle as typically applied in conventional 
VMAT applications. The resulting DVHs for the target and the 
critical structure were compared for the treatment plans. 
 
Results: The optimization of a VMAT treatment plan with a 
dynamically rotating collimator was successfully performed. 
The comparison of the DVHs for the target volume showed a 
slight improvement of the coverage as well as the dose 
homogeneity for the treatment plan using dynamic collimator 
rotation compared to the plan applying a fixed collimator 
angle. Additionally, the dose to the critical structure could 
be reduced when using the dynamic collimator rotation 
instead of a fixed collimator angle. 
 
Conclusion: The usage of a dynamic collimator rotation for 
VMAT is feasible and has the potential to improve the dose 
distribution for the target while reducing the dose to critical 
structures. This work was supported by Varian Medical 
Systems. 
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Purpose or Objective: Several studies suggest that IMRT can 
reduce toxicity in rectal cancer patients. A preconfigured 
plan model might improve daily clinical activity outcomes. 
Aim of this study was the evaluation of the performances of 
RapidPlan®Varian Medical System, a commercial model-
